Published by Wanda Rich
Posted on October 4, 2021
Big data and analytics will drive patient outcomes in a big way, and the coming years will witness a growing emphasis on healthcare service providers in the business of gathering and processing patient health data. Creating outcome-oriented financial models to maximize reimbursements in value-based healthcare will be a strategic shift from the traditional fees-for-services model. This implies that pharmaceutical companies will need to devise appropriate measures to optimize costs and improve the quality of patient care.
Burden of mental illness on Europe’s economy is among the largest in the world, inadvertently making it the most lucrative region for players in the behavioural health treatment market, with the region slated to account for a staggering 47% of the global market by 2027. Total cost associated with mental health treatment amounted to around US$ 668 Bn in 2018 across the EU, translating to 4% of the GDP of Europe. Taking cue from this opportunity, key players are striving to expand their treatment facilities to offer easy accessibility to patients.
For More Insights Into The Market, Request a Sample of this Report –
https://www.factmr.com/connectus/sample?flag=S&rep_id=4370
However, uneven distribution of therapy facilities and rehabilitation centres in rural regions across the globe is projected to result in sluggish growth of the behavioural health treatment market, with an estimated CAGR of 2.4% during the forecast period (2020-2027).
A senior analyst at Fact.MR opines,“Advent of on-demand service model will remain crucial for the behavioural health treatment market, especially in developing regions, on account of high social stigma related to opting for mental health therapy. Additionally, value-based subscription models offered by on-demand counselling would be easy on the pockets of patients, which is projected to drive a massive shift from hospital and outpatient-based care to home-based care.”
Access Research Methodology Prepared By Experts –
https://www.factmr.com/connectus/sample?flag=S&rep_id=4370
| Disorder |
|
| Service |
|
| Region |
|
Full Access of this Report Is Available At
https://www.factmr.com/checkout/4370
Although the behavioural health treatment market boasts of a number of organized players, numerous individual practitioners operating at regional and local levels generate a significant chunk of revenue. Lack of stringent regulations for practicing behavioural health services reduces the entry barrier in the market, and further adds a layer of fragmentation to the behavioural health treatment market.
Key focus of players to strengthen their foothold in the behavioural health treatment market remains on the expansion of inpatient care facilities. For instance, in January 2019, Acadia Healthcare announced the acquisition of Whittier Pavilion, which is an inpatient psychiatric facility with 71 beds. In May 2019, MercyOne Central Iowa and Universal Health Services, Inc. established a new facility at Iowa, with 100 beds, to offer high quality services for behavioural health.
For More Insights https://www.biospace.com/article/bone-marrow-processing-systems-growth-driven-by-progressions-in-bone-marrow-needles-and-harvest-technology-says-fact-mr/
Fact.MR, in its new offering, brings to the fore an unbiased analysis of the global behavioural health treatment market, presenting historical demand data (2017-2019), and forecast statistics for the period 2020-2027. The study divulges compelling insights on the behavioural health treatment market on the basis of disorder (depression, anxiety, schizophrenia, bipolar disorder, alcohol use disorders, substance use disorders, eating disorders, post-traumatic stress disorders (PSTD), and others), service (inpatient hospital treatment services, outpatient counselling, emergency mental health services, home-based treatment services, and others), across five major regions.
About Us:
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.
Contact:
The post Demand for Behavioural Health Treatment Software Is Estimated CAGR of 2.4% Over the Assessment Period appeared first on Latest Market Reports.
Big data and analytics will drive patient outcomes in a big way, and the coming years will witness a growing emphasis on healthcare service providers in the business of gathering and processing patient health data. Creating outcome-oriented financial models to maximize reimbursements in value-based healthcare will be a strategic shift from the traditional fees-for-services model. This implies that pharmaceutical companies will need to devise appropriate measures to optimize costs and improve the quality of patient care.
Burden of mental illness on Europe’s economy is among the largest in the world, inadvertently making it the most lucrative region for players in the behavioural health treatment market, with the region slated to account for a staggering 47% of the global market by 2027. Total cost associated with mental health treatment amounted to around US$ 668 Bn in 2018 across the EU, translating to 4% of the GDP of Europe. Taking cue from this opportunity, key players are striving to expand their treatment facilities to offer easy accessibility to patients.
For More Insights Into The Market, Request a Sample of this Report –
https://www.factmr.com/connectus/sample?flag=S&rep_id=4370
However, uneven distribution of therapy facilities and rehabilitation centres in rural regions across the globe is projected to result in sluggish growth of the behavioural health treatment market, with an estimated CAGR of 2.4% during the forecast period (2020-2027).
A senior analyst at Fact.MR opines,“Advent of on-demand service model will remain crucial for the behavioural health treatment market, especially in developing regions, on account of high social stigma related to opting for mental health therapy. Additionally, value-based subscription models offered by on-demand counselling would be easy on the pockets of patients, which is projected to drive a massive shift from hospital and outpatient-based care to home-based care.”
Access Research Methodology Prepared By Experts –
https://www.factmr.com/connectus/sample?flag=S&rep_id=4370
| Disorder |
|
| Service |
|
| Region |
|
Full Access of this Report Is Available At
https://www.factmr.com/checkout/4370
Although the behavioural health treatment market boasts of a number of organized players, numerous individual practitioners operating at regional and local levels generate a significant chunk of revenue. Lack of stringent regulations for practicing behavioural health services reduces the entry barrier in the market, and further adds a layer of fragmentation to the behavioural health treatment market.
Key focus of players to strengthen their foothold in the behavioural health treatment market remains on the expansion of inpatient care facilities. For instance, in January 2019, Acadia Healthcare announced the acquisition of Whittier Pavilion, which is an inpatient psychiatric facility with 71 beds. In May 2019, MercyOne Central Iowa and Universal Health Services, Inc. established a new facility at Iowa, with 100 beds, to offer high quality services for behavioural health.
For More Insights https://www.biospace.com/article/bone-marrow-processing-systems-growth-driven-by-progressions-in-bone-marrow-needles-and-harvest-technology-says-fact-mr/
Fact.MR, in its new offering, brings to the fore an unbiased analysis of the global behavioural health treatment market, presenting historical demand data (2017-2019), and forecast statistics for the period 2020-2027. The study divulges compelling insights on the behavioural health treatment market on the basis of disorder (depression, anxiety, schizophrenia, bipolar disorder, alcohol use disorders, substance use disorders, eating disorders, post-traumatic stress disorders (PSTD), and others), service (inpatient hospital treatment services, outpatient counselling, emergency mental health services, home-based treatment services, and others), across five major regions.
About Us:
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.
Contact:
The post Demand for Behavioural Health Treatment Software Is Estimated CAGR of 2.4% Over the Assessment Period appeared first on Latest Market Reports.
Explore more articles in the Research Reports category
